Infinitopes

Develops off-the-shelf precision cancer vaccines for cancer patients, using tumour-specific targets and engineered viral vectors

Oxford, United KingdomFounded 2021infinitopes.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-07

About Infinitopes

Infinitopes develops precision vaccines intended to prevent deaths from cancer metastases. Its discovery pipeline combines tumour immunopeptidome measurement with AI/ML trained on patient-sample data to identify shared, tumour-specific targets; its engineered viral vectors are designed to induce durable CD8 T-cell protection.

The company is based at Oxford University’s BioEscalator in Oxford, United Kingdom. It spun out of Oxford University in 2021 and closed a seed round in December 2023. Its stated plan was to begin enrolment in a Phase I/IIa clinical trial in H2 2025.

Product: Precision cancer vaccine candidates and discovery and viral-vector platforms for identifying tumour antigens and developing vaccines.

Jobs at Infinitopes

No open positions listed right now.

Leadership

  • Jonathan Kwok · Co-Founder, President & Chief Medical Officer
  • Lian Ni Lee · VP IMMUNOLOGY & CO-FOUNDER
  • Dan Menichella · Interim Chief Executive Officer
  • Jo Brewer · Chief Scientific Officer & Interim Chief Operating Officer

More biotech & pharma companies

  • Ingenza

    Biotechnology CRDMO developing and manufacturing biologics, pharmaceuticals and industrial products for companies
    Edinburgh Technopole, United KingdomBiotech & pharmaFounded 20023 open jobs
    New on Evolc
  • Inovia Bio

    Drug-development strategy, evidence generation and AI platforms for biotech and pharma development teams, priced per outcome
    London, United KingdomBiotech & pharmaFounded 2022
    Young companyNew on Evolc
  • Invibio

    Implant-grade PEEK polymers and biomaterial solutions for medical device manufacturers
    Cleveleys, United KingdomBiotech & pharmaFounded 2000
    New on Evolc
  • Invox Pharma

    Develops respiratory medicines and soft-mist inhaler products for patients and pharmaceutical partners
    London, United KingdomBiotech & pharmaFounded 2021
    New on Evolc
  • Iota Sciences

    Automated single-cell isolation and cloning systems and cell-line engineering services for life-sciences researchers
    Yarnton, United KingdomBiotech & pharmaFounded 2016
    New on Evolc
  • Ipsen

    Develops and sells medicines in oncology, rare diseases and neuroscience for patients and healthcare professionals
    London, United KingdomBiotech & pharmaFounded 2008192 open jobs
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

Content management

  • WebflowHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

  • AWSHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.